|
Eurobio
anti-braf v600e mutant-specific antibody clone ve1 ![]() Anti Braf V600e Mutant Specific Antibody Clone Ve1, supplied by Eurobio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/clone+ve1+(eurobio)/braf+p+v600e+directed+antibody+clone+ve1/pmc06695223-131-4-13 Average 90 stars, based on 1 article reviews
anti-braf v600e mutant-specific antibody clone ve1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Eurobio
clone ve1 (eurobio) ![]() Clone Ve1 (Eurobio), supplied by Eurobio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/clone+ve1+(eurobio)/clone+ve1++eurobio+/pmc08947166-81-15-16 Average 90 stars, based on 1 article reviews
clone ve1 (eurobio) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay
doi: 10.1371/journal.pone.0221123
Figure Lengend Snippet: Comparison of BRAF and NRAS results by allele specific amplification, Sanger sequencing, IHC and Idylla testing.
Article Snippet: Slides were stained with
Techniques: Comparison, Amplification, Sequencing, Mutagenesis
Journal: PLoS ONE
Article Title: Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay
doi: 10.1371/journal.pone.0221123
Figure Lengend Snippet: A. Control of samples found positive for BRAF mutation by ASA/Sequencing but negative by IHC. B. Control of samples found negative for BRAF mutation by ASA/sequencing and positive by IHC (wrong chromogen used). C. Control of samples found positive for NRAS mutation by sequencing but negative by Idylla. Yellow dots correspond to wild type DNA copies ( BRAF , panels A and B; NRAS , panel C). Green dots correspond to mutated DNA copies ( BRAF V600E, panels A and B; NRAS Q61R, panel C). Grey dots correspond to empty wells.
Article Snippet: Slides were stained with
Techniques: Control, Mutagenesis, Sequencing
Journal: PLoS ONE
Article Title: Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay
doi: 10.1371/journal.pone.0221123
Figure Lengend Snippet: Discordant genotyping results.
Article Snippet: Slides were stained with
Techniques: Digital PCR
Journal: Diagnostics
Article Title: Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
doi: 10.3390/diagnostics12030751
Figure Lengend Snippet: Analysis of discordant results.
Article Snippet: Vallée et al. 2019 [ ] , Melanoma (metastatic and primary) , 65 , Clone
Techniques: Diagnostic Assay, Amplification
Journal: Diagnostics
Article Title: Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
doi: 10.3390/diagnostics12030751
Figure Lengend Snippet: Example of discordant results. ( a – d ), a micro-metastatic sentinel lymph node that expressed BRAF V600E when analyzed by IHC and was negative with the BRAF Idylla test despite delayed amplification. ( e – g ), a subcutaneous melanoma metastasis considered negative for IHC BRAF V600E when compared to the control. ( g ) (some background noise due to intracytoplasmic pigment), when stained with a red chromogen the interpretation remains equivocal ( h , i ) and positive with the Idylla method. ( a , e ) HES stain ×20; ( b ) Melan A IHC ×20 (Clone A103, Roche Ventana); ( c , f ) BRAF V600E IHC ×20 (Clone VE1, Roche Ventana); ( g ) BRAF V600E IHC ×40 external control showing viable tumor cells and melanophages; ( h ) BRAF V600E IHC ×20 (Clone VE1, Roche Ventana—Red detection kit); ( i ) BRAF V600E IHC ×40 external control viable tumor cells with red chromogen; ( d , j ) Amplification curves with the Idylla Explore tool.
Article Snippet: Vallée et al. 2019 [ ] , Melanoma (metastatic and primary) , 65 , Clone
Techniques: Amplification, Control, Staining
Journal: Diagnostics
Article Title: Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
doi: 10.3390/diagnostics12030751
Figure Lengend Snippet: Overview of studies combining immunohistochemistry and Idylla for BRAF evaluation.
Article Snippet: Vallée et al. 2019 [ ] , Melanoma (metastatic and primary) , 65 , Clone
Techniques: Immunohistochemistry, Mutagenesis, Immunostaining
Journal: Diagnostics
Article Title: Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
doi: 10.3390/diagnostics12030751
Figure Lengend Snippet: Comparison of Idylla and IHC for the detection of the BRAF V600E mutation in melanomas.
Article Snippet: Vallée et al. 2019 [ ] , Melanoma (metastatic and primary) , 65 , Clone
Techniques: Comparison, Mutagenesis, Expressing, Blocking Assay, Selection